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sampling methods have been published elsewhere. [4] [5] [6] Briefly, subjects were selected by means of census lists from three different populations in central Spain in 1994-1995. Data from this baseline crosssectional evaluation were used for this study.
| Diagnosis of Parkinson's disease and diabetes
All those subjects who screened positive on the initial validated screening questionnaire for parkinsonism were assessed and examined by a senior neurologist to confirm the diagnosis of PD. 5, 6 PD was defined by the presence of two cardinal signs of bradykinesia, resting tremor, rigidity and impairment of postural reflexes (or one cardinal sign in those on antiparkinsonian medication) and exclusion of other causes of parkinsonism. Only subjects with idiopathic PD were included in the study (Table 1 ).
Diabetes was defined by self-reported diagnosis, treatment with antidiabetic medication (oral antidiabetics and/or insulin) or diagnosis present on medical records. Subjects lacking data on diabetes status
were excluded from the analysis. 
| Statistical analysis

| RESULTS
This study included 4998 subjects from a total of 6395 communitydwelling elders ( Figure 1 ). Their baseline demographic and medical characteristics are shown in 
P=.02).
A summary of the results of the statistical analysis with the associations between different groups is shown in Table 3 .
T A B L E 1 Diagnostic criteria for parkinsonism and aetiologic subgroups 5, 6 Diagnosis Criteria 
| DISCUSSION
In this large population-based cross-sectional study, we found no significant association between diabetes and PD among Spanish elderly populations. However, our results suggest that diabetes duration might be an important factor on this association and the risk of PD might be limited to those patients with long-duration diabetes as there was a significant positive association between PD and those patients with long-duration diabetes (>10-year duration).
Our study did not show a significant association between PD and diabetes in our sample population (OR 1.89, 95% CI 0.90-3.98, P=.09).
Results of observational studies evaluating this association are conflicting 9, 10 , although in recent meta-analysis of prospective studies, diabetes was found to be a risk factor for future PD (RR=1.26 [95%CI 1.03-1.55]; P<.0001).
11,12
To our knowledge, the potential time-dependent effect of the association has been assessed only in two previous studies. 7, 8 Our results are in agreement with those of the Xu et al. 8 showing that most of the risk is attributed to patients with disease duration of more than 10 years. The effect of diabetes duration is important in the interest of giving a pathophysiological explanation of the association, as if diabetes is a risk factor for PD, one will expect a higher risk among those with long history or complicated diabetes. Driver et al. 7 found that the increased risk for PD was highest among individuals with uncomplicated or short-duration diabetes (<10 years of duration) which was explained by the authors as a possible selection bias from increased medical surveillance or an underlying common biological mechanism.
The heterogeneity of the published studies, ascertainment of PD and diabetes, and the effect that environment, ethnic factors and diabetes medications might have on the association, might explain in part the inconsistency of the results. Unfortunately, detailed information on diabetes control and medications was not available in our cohort and the influence that this may have on the risk of PD could not be assessed.
One of the main strengths of our study is the confirmation of PD diagnosis by a neurologist in all cases. PD cases in our study were iden- Apart from the observational studies discussed above, there is a growing evidence from various areas of research suggesting a common link between diabetes and PD. It has been hypothesized that aberrant insulin signalling triggers a stepwise sequence of disruptions of regulatory pathways (including mitochondrial dysfunction, neuroinflammation, increased endoplasmic reticulum stress, abnormal protein aggregation and metabolic abnormalities) which would lead to insulin resistance and diabetes, and might ultimately put an individual at increased risk for PD. [1] [2] [3] In addition to a potential increased risk for PD, diabetes has also been suggested as a modifying factor of the disease contributing to more severe motor symptoms requiring higher doses 
| CONCLUSIONS
The results of this population-based cross-sectional study show no significant association between PD and diabetes but suggest a possible disease-duration-dependent effect in this relationship as there is an increased prevalence of PD in those with long-duration diabetes after adjustment for confounding factors. Diabetes duration appears to reflect the effect of the cumulative toxicity of the underlying shared pathological mechanisms between these two diseases. Future studies should further explore this possibility and the effect of good diabetes control in the association between PD and diabetes.
